Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria T Grosse Perdekamp"'
Autor:
Jennifer Le-Rademacher, Mary Wilkinson, Maria T. Grosse-Perdekamp, Charles L. Loprinzi, Kathryn J. Ruddy, Andreas S. Beutler, Mario E. Lacouture, Travis J. Dockter, Angelina D. Tan, Amy C. Vander Woude, Adedayo A. Onitilo
Publikováno v:
Breast
Purpose This pilot trial aimed to assess if cooling hands and feet with crushed ice during receipt of paclitaxel helps prevent peripheral neuropathy. Methods This prospective, randomized trial compared cryotherapy to standard care in patients initiat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::949b1e2ebb0fefd1d89a8140a3ad61a7
https://pubmed.ncbi.nlm.nih.gov/31590108
https://pubmed.ncbi.nlm.nih.gov/31590108
Autor:
Adedayo A. Onitilo, Angelina D. Tan, Andreas S. Beutler, Travis J. Dockter, Mario E. Lacouture, Maria T. Grosse Perdekamp, Mary Wilkinson, Charles L. Loprinzi, Amy C. Vander Woude, Kathryn J. Ruddy, Jennifer Le-Rademacher
Publikováno v:
Journal of Clinical Oncology. 36:e22075-e22075
e22075Background: Cooling the extremities during chemotherapy has been hypothesized to reduce subsequent peripheral neuropathy. Methods: A randomized pilot trial was conducted comparing cryotherapy...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cd567500776c0f52ed88818b3b4d249
https://doi.org/10.1200/jco.2018.36.15_suppl.e22075
https://doi.org/10.1200/jco.2018.36.15_suppl.e22075
Autor:
Sandra P. D’ Angelo, Eliza Woodward Hartley, Jason J. Luke, Cristina R. Antonescu, Mercedes M. Condy, Michelle R. Mahoney, Douglas Adkins, Maria T. Grosse Perdekamp, Brian A. Van Tine, Gary K. Schwartz, William D. Tap
Angiosarcomas are rare malignant endothelial cell tumors which have up-regulation of the angiopoietin system [e.g., Tie2 and Angiopoietin 2 (Ang2)]. Trebananib is a novel agent targeting Angiopoietin 1 and Angiopoietin 2.Trebananib 30 mg/kg was admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ffb10102e71ae33cce8ad280f8792a
https://europepmc.org/articles/PMC4699670/
https://europepmc.org/articles/PMC4699670/
Publikováno v:
Blood Coagulation & Fibrinolysis. 17:593-597
A woman with gross hematuria was shown to have a severe isolated factor V deficiency due to a factor V inhibitor of 200 U/ml titer. Hematuria persisted despite multiple infusions of plasma but, after one transfusion with 1 U platelets, urine red bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1561ccb20d0c233f480436d2ea0bdea2
https://doi.org/10.1097/01.mbc.0000245297.64644.ee
https://doi.org/10.1097/01.mbc.0000245297.64644.ee
Autor:
Barbara, Schubert, Maria T, Grosse Perdekamp, Petra, Pfeuffer, Petra, Raith, Eva-B, Bröcker, Axel, Trautmann
Publikováno v:
European journal of dermatology : EJD. 15(3)
In the medical community lectures and publications about nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity have led to an increasing awareness and diagnosis of this condition. Frequently, the diagnosis NSAID hypersensitivity is based only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7363d72df8a73432d7a73d4afff466f1
https://pubmed.ncbi.nlm.nih.gov/15908299
https://pubmed.ncbi.nlm.nih.gov/15908299
Autor:
Sandra P. D'Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, Douglas Adkins, Maria T. Grosse Perdekamp, Mercedes M. Condy, Eliza Woodward Hartley, Cristina R. Antonescu, Gary K. Schwartz, William D. Tap
Publikováno v:
Journal of Clinical Oncology. 32:10568-10568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4f8c16684ba109c206de1cad465e2e0
https://doi.org/10.1200/jco.2014.32.15_suppl.10568
https://doi.org/10.1200/jco.2014.32.15_suppl.10568
Autor:
Brian A. Van Tine, Mercedes M. Condy, Gary K. Schwartz, Eliza Woodward Hartley, Sandra P. D'Angelo, Cristina R. Antonescu, Douglas Adkins, William D. Tap, Michelle R. Mahoney, Maria T. Grosse Perdekamp
Publikováno v:
Journal of Clinical Oncology. 31:TPS10592-TPS10592
TPS10592 Background: Angiosarcomas (ASs) are rare, aggressive, malignant endothelial cell tumors that constitute 1% to 2% of all soft tissue sarcomas with 5-year survival of 35%. Cytotoxic agents have demonstrated response rates of about 15%. Gene-ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9644724a16b9e3a7fc9ac57ab548d5cf
https://doi.org/10.1200/jco.2013.31.15_suppl.tps10592
https://doi.org/10.1200/jco.2013.31.15_suppl.tps10592